Boston Scientific (BSX) Share-based Compensation (2009 - 2026)

Boston Scientific has disclosed Share-based Compensation across 18 years of filings, most recently posting $61.0 million for Q2 2026.

• In Q2 2026, Share-based Compensation fell 15.28% year-over-year to $61.0 million; the TTM figure through Jun 2026 stood at $320.0 million (up 11.89% YoY), while the FY2025 annual figure was $299.0 million, up 12.41% from the prior year.
• Share-based Compensation came in at $61.0 million for Q2 2026 at Boston Scientific, down from $109.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $140.0 million in Q1 2022 to a low of -$78.0 million in Q4 2022.
• Average Share-based Compensation over 5 years is $66.0 million, with a median of $67.0 million recorded in 2024.
• The largest YoY upside for Share-based Compensation was 198.18% in 2022 against a maximum downside of 259.18% in 2022.
• Over 5 years, Share-based Compensation stood at -$78.0 million in 2022, then jumped by 175.64% to $59.0 million in 2023, then gained by 16.95% to $69.0 million in 2024, then increased by 2.9% to $71.0 million in 2025, then slipped by 14.08% to $61.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $61.0 million in Q2 2026, $109.0 million in Q1 2026, and $71.0 million in Q4 2025.